Background:

Garlic extract (Allium sativum L.) is a clinically validated nutraceutical with broad applications across cardiovascular, metabolic, hepatic, infectious, neuro-inflammatory, and barrier-related disorders.

Contemporary research supports its therapeutic effects through a unifying biochemical framework - the Redox–Inflammatory–Metabolic/Barrier Tri-Axis - which integrates redox homeostasis, immune regulation, and metabolic reprogramming.

Organosulfur compounds, particularly allicin, S-allyl cysteine, and diallyl disulfide, exert electrophilic control over oxidative and inflammatory signaling pathways, enabling systemic restoration rather than symptomatic suppression.

Methods:

This review synthesizes findings from randomized controlled trials, meta-analyses, and mechanistic studies evaluating garlic extract as a single or combined intervention.

Human data were prioritized to assess clinical efficacy and translational mechanisms across five disease categories:

(1) Cardiovascular–metabolic disorders (atherosclerosis, metabolic syndrome, Type II Diabetes Mellitus, and non-alcoholic fatty liver disease);

(2) Infectious and post-infectious conditions (upper-respiratory, oral, and viral inflammations);

(3) Hepatic and gastrointestinal disorders;

(4) Neurodegenerative and neuro-inflammatory diseases; and

(5) Epithelial and mucosal barrier dysfunctions. Mechanistic evidence was mapped along three intersecting axes: redox–inflammatory balance, microbial–barrier synchronization, and immunometabolic–endocrine integration.

Results:

Across cardiovascular and metabolic studies, garlic extract improved lipid and glucose regulation, enhanced endothelial function, and reduced inflammatory biomarkers through activation of Nrf2–HO-1, inhibition of NF-κB and NLRP3 inflammasome, and reactivation of AMPK–PGC-1α signaling.

In infectious and mucosal conditions, garlic reduced oxidative and cytokine stress, reinforced tight-junction proteins, and promoted fibroblast-driven repair, leading to shorter recovery times and reduced recurrence rates.

In hepatic and gastrointestinal pathologies, supplementation lowered ALT/AST levels, decreased hepatic steatosis, and improved gut–liver redox balance through PPARα and CPT-1 activation.

Neuro-inflammatory research demonstrated suppression of microglial M1 polarization and protection of mitochondrial integrity via Nrf2–GSH coupling, supporting neuroprotection in degenerative models.

Barrier repair studies revealed enhanced collagen synthesis, angiogenesis, and structural regeneration through coordinated activation of PI3K–Akt, TGF-β/Smad3, and VEGF signaling.

Discussion:

The consistent clinical outcomes across organ systems confirm that garlic extract functions as a systems-level modulator aligning redox, immune, and metabolic homeostasis.

Its electrophilic–antioxidant synergy transforms oxidative instability into adaptive repair, establishing a nutritional pharmacology paradigm distinct from classical pharmacotherapy.

The integration of garlic extract with polyphenolic agents such as propolis further amplifies redox control, cytokine reprogramming, and tissue regeneration, illustrating a viable model for multi-nutrient therapeutic design.

Conclusion:

Garlic extract operates through a multidimensional biochemical framework that synchronizes redox defense, inflammation resolution, mitochondrial recovery, and barrier reconstruction.

Human clinical evidence substantiates its role as a nutritional immunometabolic regulator, capable of addressing complex chronic diseases through coordinated molecular adaptation rather than isolated pharmacologic inhibition.

The Redox–Inflammatory–Metabolic/Barrier Tri-Axis therefore represents an evidence-based platform for the development of next-generation, systems-oriented nutraceutical interventions.